H.R. 3927 · 117th Congress
MADE in America Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
CarterSponsor14 cosponsors · 2 D, 12 R
R
Crawford
MC
D
Cartwright
HG
R
Griffith
DM
R
McKinley
TR
R
Rice
DS
D
Soto
JV
R
Van Drew
BW
R
Westerman
TB
R
Balderson
JK
R
Katko
RH
R
Hudson
RJ
R
Jackson
MM
R
Mullin
ND
R
Dunn8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act
What it does: CRS summary · Introduced in House · Jun 16, 2021
Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act
This bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals.
An eligible taxpayer may claim a tax credit equal to 25% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%. The bill provides for increases to this tax credit in certain situations, such as if a substantial portion of the employees reside in areas with certain poverty levels.
In addition, the Food and Drug Administration (FDA) must continue programs to facilitate the development and review of new drug or biological products that are manufactured using certain advanced manufacturing technologies. The bill imposes various requirements on these programs, including deadlines for evaluating such a technology.
Furthermore, the Department of Health and Human Services must ensure timely and effective internal coordination and alignment between FDA field investigators and the staff of the Center for Drug Evaluation and Research's Office of Compliance and Drug Shortage Program regarding reports and feedback related to facility inspections.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: MADE in America Act
Also known as: Manufacturing API, Drugs, and Excipients in America Act
Latest action (Jun 17, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jun 16, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.